Status | Study |
Completed |
Study Name: Neural Basis of Language Processing Condition: Oligoastrocytoma Astrocytoma Date: 2016-09-13 Interventions: Device: fMRI Patient with grad |
Recruiting |
Study Name: Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA Condition: Glioblastoma Anaplastic Astrocytoma Anaplastic Date: 2016-05-27 Interventions: Drug: Intra-arterial Cetuximab Drug: Intra |
Not yet recruiting |
Study Name: Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas Condition: Glioma Anaplastic Oligoastrocytoma Date: 2016-05-24 Interventions: Procedure: Structural Image Guidance |
Recruiting |
Study Name: A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment Condition: Anaplastic Oligoastrocytoma Anaplastic Astrocytoma Date: 2015-12-10 Interventions: Drug: β-elemene β-elemene 600mg/d,ivdrip,d1-14,every 28 days for 1 cycle, totally 6 cycles |
Recruiting |
Study Name: Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved Condition: Oligodendroglioma Oligoastrocytoma Date: 2015-08-18 Interventions: Drug: Palbociclib Palbociclib will be administered orally at a dose of 125 mg/day, until disease progres |
Completed |
Study Name: A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas Condition: Astrocytoma Oligodendroglioma Oligoa Date: 2014-07-30 Interventions: Drug: Temozolomide 75 mg/m2/day for 21 days repeated every 4 weeks, 6 cycles. |
Recruiting |
Study Name: A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma Condition: Glioblastoma Multiforme Anaplastic Oligoastrocytoma Date: 2013-12-16 Interventions: Biological: INXN-2001 |
Completed |
Study Name: Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial Condition: Anaplastic Oligodendroglioma Anaplastic Oligoastrocytoma Date: 2013-04-29 Interventions: Drug: Temozolomide Temozolomide 200 mg/m2/d in a fasting state for 5 consecutive days (1,000 mg/m2 per 2 |
Recruiting |
Study Name: A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas Condition: Anaplastic Oligoastrocytoma Anaplastic Astrocytoma Date: 2013-01-07 Interventions: Drug: Temozolomide dosed at 20 |
Withdrawn |
Study Name: Re-irradiation of High Grade Gliomas: a Quality of Life Study Condition: Anaplastic Astrocytoma Glioblastoma Multiforme Anaplastic Date: 2012-10-12 Interventions: Other: EORTC QLQ-C30 The EORTC |